Sponsors (27)
Introduced March 30, 2026 by Yassamin Ansari · Last progress March 30, 2026
The bill boosts recognition, research, training, and outreach to improve diagnosis and care for people with PMDD—particularly benefiting women and underserved groups—but does so through open-ended multi-year federal authorizations that may take years to yield results, increase public spending, risk uneven implementation, and could unintentionally broaden medicalization if not carefully executed.
Women with PMDD (and people who experience cyclical mood symptoms) will be more likely to be recognized, diagnosed, and connected to treatment because the bill elevates PMDD in federal research, reporting, outreach, and clinical guidance.
Clinicians and health systems will receive targeted training, CME materials, curricula grants, and clinical guidance that improve provider ability to diagnose and treat PMDD and mid-life women’s health.
Federal-supported research, data collection, and a required HHS report will expand knowledge about PMDD, enabling development of better treatments and evidence-based clinical guidance over time.
Taxpayers face higher federal spending because multiple provisions authorize open-ended 'such sums as are necessary' over several years without specified caps.
Research, reporting, and program rollouts will take time (reports due in about two years and multi-year research timelines), so patients may not see timely improvements in care or treatments.
Authorization alone does not guarantee funding—if Congress does not appropriate funds, required activities and promised improvements may not occur.
Based on analysis of 6 sections of legislative text.
Directs HHS/NIH to expand PMDD research, collect data, run awareness/CME campaigns, fund clinician training grants, and report progress to Congress with authorized funding.
Requires the Department of Health and Human Services (through NIH and other HHS agencies) to expand research on Premenstrual Dysphoric Disorder (PMDD), collect and publish data on its prevalence and impacts, run a public awareness campaign and continuing medical education for providers, fund training programs for clinicians, and report progress to Congress. The bill authorizes unspecified (“such sums as necessary”) appropriations across several fiscal years to support research, education, training, outreach, and the required report.